What You Should Know:
– Mayo Clinic Platform_Accelerate has announced its latest cohort of health tech startups, featuring national and international businesses poised to transform healthcare.
– These 11 companies will participate in an immersive, 30-week program, gaining unparalleled access to expert mentors, industry-leading technologies, and millions of de-identified, longitudinal clinical records to develop and validate their artificial intelligence (AI)-driven healthcare solutions.
A Unique Ecosystem for Validation and Scale
The Accelerate program is designed to bridge the gap between technological innovation and clinical expertise. Participants will have access to Mayo Clinic experts across regulatory, clinical, technology, and business domains, alongside top investors and healthcare leaders. This unique arrangement provides the resources, relationships, and credibility essential for scaling ambitious healthcare ventures.
“The only way we can transform healthcare is by bringing together clinical experts with technology innovators,” said John Halamka, M.D., Diercks President of Mayo Clinic Platform. “Our Accelerate program connects innovative startups with Mayo Clinic physicians and scientists to turn breakthrough ideas into real-world healthcare solutions.”.
Introducing the October Cohort: Tackling Healthcare’s Biggest Challenges
The new cohort features a diverse group of companies focused on some of healthcare’s most pressing issues, from early diagnostics to chronic disease management:
- Bowhead Health is developing a radiogenomics platform that uses imaging to predict genomic mutations and guide personalized treatment and clinical trial matching.
- Cleancard is creating an AI-powered, at-home cancer detection test that delivers lab-grade diagnostics in 30 minutes.
- Dart Health rapidly deploys hospital-wide AI solutions by embedding engineering teams on-site to solve clinical and operational challenges.
- Kanjo Health uses AI and evidence-based insights to deliver earlier, personalized, and scalable care for children with attention-deficit/hyperactivity disorder (ADHD) and autism.
- Koroid’s intelligent platform predicts clinical demand and automates healthcare logistics to utilize staff and resources efficiently, cost-effectively, and safely, leading to better quality care.
- MedLink Global is advancing AI-driven precision psychiatry with tools that deliver accurate diagnoses and personalized treatment guidance.
- MyAtlas Health leverages AI and data from wearable devices to predict mental health crises early and deliver personalized, preventive support.
- Ordinatrum Health enhances critical care through AI-powered, FDA-cleared virtual intensive care units (ICU) and data integration solutions.
- Promed AI combines at-home testing and multimodal AI to deliver affordable, personalized preventive healthcare.
- RTHM provides data-driven, technology-enabled care to improve the diagnosis of and treatment for complex chronic illnesses like long COVID, myalgic encephalomyelitis, and chronic fatigue syndrome.
- Radical is developing a general-purpose AI model for oncology that generates personalized treatment recommendations to improve outcomes and reduce costs.
